Patient-reported outcomes in first-line antiretroviral therapy: results from NEAT001/ANRS143 trial comparing darunavir/ritonavir in combination with tenofovir/emtricitabine or raltegravir

BACKGROUND: There are few data comparing patient reported outcomes (PROs) in randomized trials of initial antiretroviral therapy (ART). We present results from a substudy of the NEAT001/ANRS143 trial. METHODS: The randomized trial compared first-line DRV/r 800/100mg once daily plus RAL 400mg twice d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Acquir Immune Defic Syndr
Main Authors: George, Elizabeth C, Bucciardini, Raffaella, Richert, Laura, Dedes, Nikos, Fragola, Vincenzo, Nieuwkerk, Pythia, Spire, Bruno, Volny-Anne, Alain, West, Brian, Molina, Jean-Michel, Horban, Andrzej, Fox, Julie, Pozniak, Anton, Vella, Stefano, Termote, Monique, Raffi, François
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6420069/
https://ncbi.nlm.nih.gov/pubmed/30234665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000001844
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados